144 related articles for article (PubMed ID: 4040799)
1. Cisplatin in recurrent pediatric brain tumors. A POG Phase II study. A Pediatric Oncology Group Study.
Sexauer CL; Khan A; Burger PC; Krischer JP; van Eys J; Vats T; Ragab AH
Cancer; 1985 Oct; 56(7):1497-501. PubMed ID: 4040799
[TBL] [Abstract][Full Text] [Related]
2. A phase II study of cisplatin therapy in recurrent childhood brain tumors. A report from the Childrens Cancer Study Group.
Bertolone SJ; Baum ES; Krivit W; Hammond GD
J Neurooncol; 1989 May; 7(1):5-11. PubMed ID: 2754456
[TBL] [Abstract][Full Text] [Related]
3. PCNU in the treatment of recurrent medulloblastoma and ependymoma--a POG Study.
Ragab AH; Burger P; Badnitsky S; Krischer J; Van Eys J
J Neurooncol; 1986; 3(4):341-2. PubMed ID: 3958779
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study.
Hurwitz CA; Strauss LC; Kepner J; Kretschmar C; Harris MB; Friedman H; Kun L; Kadota R
J Pediatr Hematol Oncol; 2001; 23(5):277-81. PubMed ID: 11464982
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin in the treatment of recurrent childhood primary brain tumors.
Walker RW; Allen JC
J Clin Oncol; 1988 Jan; 6(1):62-6. PubMed ID: 2826716
[TBL] [Abstract][Full Text] [Related]
6. Phase II evaluation of dibromodulcitol in the treatment of recurrent medulloblastoma, ependymoma, and malignant astrocytoma.
Levin VA; Edwards MS; Gutin PH; Vestnys P; Fulton D; Seager M; Wilson CB
J Neurosurg; 1984 Dec; 61(6):1063-8. PubMed ID: 6502234
[TBL] [Abstract][Full Text] [Related]
7. A phase II evaluation of thiotepa in pediatric central nervous system malignancies.
Heideman RL; Packer RJ; Reaman GH; Allen JC; Lange B; Horowitz ME; Steinberg SM; Gillespie A; Kovnar EH; Balis FM
Cancer; 1993 Jul; 72(1):271-5. PubMed ID: 8508417
[TBL] [Abstract][Full Text] [Related]
8. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
Nicholson HS; Kretschmar CS; Krailo M; Bernstein M; Kadota R; Fort D; Friedman H; Harris MB; Tedeschi-Blok N; Mazewski C; Sato J; Reaman GH
Cancer; 2007 Oct; 110(7):1542-50. PubMed ID: 17705175
[TBL] [Abstract][Full Text] [Related]
9. Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial.
Gaynon PS; Ettinger LJ; Baum ES; Siegel SE; Krailo MD; Hammond GD
Cancer; 1990 Dec; 66(12):2465-9. PubMed ID: 2249186
[TBL] [Abstract][Full Text] [Related]
10. Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group study.
Mulne AF; Ducore JM; Elterman RD; Friedman HS; Krischer JP; Kun LE; Shuster JJ; Kadota RP
J Pediatr Hematol Oncol; 2000; 22(1):41-4. PubMed ID: 10695820
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors.
Corden BJ; Strauss LC; Killmond T; Carson BS; Wharam MD; Kumar AJ; Piantadosi S; Robb PA; Phillips PC
J Neurooncol; 1991 Aug; 11(1):57-63. PubMed ID: 1919647
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin therapy in recurrent childhood brain tumors.
Khan AB; D'Souza BJ; Wharam MD; Champion LA; Sinks LF; Woo SY; McCullough DC; Leventhal BG
Cancer Treat Rep; 1982 Dec; 66(12):2013-20. PubMed ID: 6890409
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of recurrent pediatric posterior fossa tumors.
Edwards MS; Levin VA; Wilson CB
Clin Neurosurg; 1983; 30():209-25. PubMed ID: 6667576
[No Abstract] [Full Text] [Related]
14. Phase II study of ifosfamide in childhood brain tumors: a report by the French Society of Pediatric Oncology (SFOP).
Chastagner P; Sommelet-Olive D; Kalifa C; Brunat-Mentigny M; Zucker JM; Demeocq F; Baranzelli MC; Tron P; Bergeron C; Pein F
Med Pediatr Oncol; 1993; 21(1):49-53. PubMed ID: 8381203
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cisplatin in children with recurrent brain tumors.
Diez B; Monges J; Muriel FS
Cancer Treat Rep; 1985; 69(7-8):911-3. PubMed ID: 4040429
[No Abstract] [Full Text] [Related]
16. Phase II study of cisplatin in recurrent astrocytomas in adults: a Southwest Oncology Group Study.
Stewart DJ; O'Bryan RM; Al-Sarraf M; Costanzi JJ; Oishi N
J Neurooncol; 1983; 1(2):145-7. PubMed ID: 6088711
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of every other day high-dose ifosfamide in pediatric brain tumors: a Pediatric Oncology Group Study.
Heideman RL; Douglass EC; Langston JA; Krischer JP; Burger PC; Kovnar EH; Kun LE; Friedman HS; Kadota R
J Neurooncol; 1995; 25(1):77-84. PubMed ID: 8523093
[TBL] [Abstract][Full Text] [Related]
18. Carboplatin and recurrent childhood brain tumors.
Allen JC; Walker R; Luks E; Jennings M; Barfoot S; Tan C
J Clin Oncol; 1987 Mar; 5(3):459-63. PubMed ID: 3546620
[TBL] [Abstract][Full Text] [Related]
19. Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine.
Lefkowitz IB; Packer RJ; Siegel KR; Sutton LN; Schut L; Evans AE
Cancer; 1990 Feb; 65(3):412-7. PubMed ID: 2153428
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of fotemustine in pediatric patients with refractory brain tumors.
Hargrave DR; Bouffet E; Gammon J; Tariq N; Grant RM; Baruchel S
Cancer; 2002 Sep; 95(6):1294-301. PubMed ID: 12216098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
